Compare CLDX & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | BLBD |
|---|---|---|
| Founded | N/A | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2008 | N/A |
| Metric | CLDX | BLBD |
|---|---|---|
| Price | $25.87 | $51.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $44.10 | ★ $64.60 |
| AVG Volume (30 Days) | ★ 718.4K | 437.6K |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.79 |
| EPS | N/A | ★ 3.88 |
| Revenue | $2,599,000.00 | ★ $1,480,099,000.00 |
| Revenue This Year | N/A | $4.86 |
| Revenue Next Year | $19.70 | $3.41 |
| P/E Ratio | ★ N/A | $13.27 |
| Revenue Growth | N/A | ★ 9.87 |
| 52 Week Low | $14.40 | $30.04 |
| 52 Week High | $30.50 | $61.95 |
| Indicator | CLDX | BLBD |
|---|---|---|
| Relative Strength Index (RSI) | 44.96 | 51.66 |
| Support Level | $24.97 | $51.09 |
| Resistance Level | $28.79 | $52.55 |
| Average True Range (ATR) | 1.36 | 1.43 |
| MACD | -0.36 | 0.16 |
| Stochastic Oscillator | 16.46 | 65.92 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.